Navigation Links
DuPont Innovation Addressing Major Global Market Trends
Date:5/28/2009

CEO Ellen Kullman Updates Investors on Growth Opportunities in Increasing Food Productivity, Decreasing Dependence on Fossil Fuels, Protecting Lives, Growing in Emerging Markets

NEW YORK, May 28 /PRNewswire-FirstCall/ -- DuPont (NYSE: DD) is well-positioned for growth opportunities with innovations that are addressing major global market trends, said DuPont CEO Ellen J. Kullman at an investors' conference here today. Kullman said the company's research and development efforts are focused on global needs for increasing food productivity, decreasing dependence on fossil fuels, protecting lives and growing in emerging markets.

"DuPont is a market-driven science company," Kullman said at the Sanford Bernstein Strategic Decisions Conference. "That simple statement describes us whether we're at the peak of an economic cycle or experiencing a global recession -- innovation is a critical lever at all times for DuPont. Our innovation objectives are focused on key global market trends. These trends provide a compass to guide our research and development on new products, creating opportunities for innovation by DuPont."

Kullman said 77 percent of DuPont's $1.4 billion R&D budget is directed at three global "megatrends" of increasing food productivity, decreasing dependence on fossil fuels and protecting lives. With greater emphasis on the execution of its product development efforts, DuPont delivered more than $10 billion in sales from new products that are less than five years old in 2008. In first quarter 2009, DuPont commercialized more than 500 new products to the market -- nearly double compared to first quarter 2008.

"Innovation has the potential to better feed the world, address global energy challenges and provide safer and more secure lives for people everywhere. DuPont is pursuing innovati
'/>"/>

SOURCE DuPont
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. DuPont Receives Canadian Regulatory Approval for High Oleic Soybean Trait
2. DuPont Statement on Obama Administration Biofuels Interagency Working Group
3. DuPont Leader: Agriculture is Up to Global Productivity Challenge
4. DuPont and Chinese Academy of Agricultural Sciences Collaborate to Advance Crop Insect Control, Increase Yield
5. DuPont Partners with Indonesian Center for Rice Research to Advance Hybrid Rice
6. DuPont and International Rice Research Institute Partner to Boost Rice Yields
7. DuPont Biotech Stewardship Program Gains External Certification
8. DuPont Expects Increased Global Seed Corn Share, Continued Agriculture Earnings Growth
9. DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans
10. DuPont Acquires Ag Data Management Business to Enhance Information Solutions for Growers
11. DuPont Unveils New Strategy to Expand its Seed Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 05, 2015 North Carolina-based ... Noel, M.D., Professor of Medicine, Mayo Clinic College ... Board of Directors. , Entegrion’s Executive ... fortunate to have Dr. Noel, a distinguished physician ... organization, join Entegrion’s Board. His expertise in hematology ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ) has ... 2015: New Therapy Ventures Pave the Way for Success" ... biotech companies - Gilead (GILD), Amgen (AMGN), Biogen Idec ... a positive return and hence increased the interest of ... therapy/niche indication where the high treatment cost justifies the ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 The next ... have received the CE mark (European) approval. The CE ... Free Trade Association (EFTA) and the European Union. Following ... now been granted to implants supplied by the Turkey-based ... conditions. , Osimplant's Cervical Expandable Bladed HA PEEK ...
(Date:3/4/2015)... In an article published and posted online ... Security review the clinical aspects of diseases caused by ... The article, "Clinical Management of Potential Bioterrorism-Related Conditions," was ... the New England Journal of Medicine . ... and Tom Inglesby—review the clinical management of conditions resulting ...
Breaking Biology Technology:Entegrion Announces Appointment of Pierre Noel, MD, to Its Board of Directors 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3Latest Clinical Information On Bioterrorism Threats 2
... 2011 Palatin Technologies, Inc. (NYSE Amex: PTN ... 23rd Annual OC Growth Stock Conference on Tuesday, March 15, ... held at the Ritz Carlton Laguna Niguel in Dana Point, ... Executive Officer of Palatin Technologies, will provide an update on ...
... 2011 AccessClosure, Inc., the U.S. market segment ... from the first published study* (Journal of NeuroInterventional ... different vascular closure devices (VCD) as the primary ... the discomfort associated with the Mynx 5F Vascular ...
... UBM Live and its sister company, UBM Japan ... and new developments taking place at the tenth anniversary of ... 18-20 April, 2011 at the Big Sight Exhibition Center in ... P-MEC Japan, which covers Pharma machinery and equipment, ICSE Japan, ...
Cached Biology Technology:Significant Reduction in Pain With the Mynx Vascular Closure Device Versus Angio-Seal Device 2Significant Reduction in Pain With the Mynx Vascular Closure Device Versus Angio-Seal Device 3UBM Announces Content for 10th Annual Japanese Pharma & Bio Events 2UBM Announces Content for 10th Annual Japanese Pharma & Bio Events 3UBM Announces Content for 10th Annual Japanese Pharma & Bio Events 4
(Date:1/22/2015)... Fla. , Jan. 13, 2015  Today, FreeWavz ... technology, launched its crowdfunding campaign on Fundable, ... the build of production capacity to meet customer ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
(Date:1/22/2015)... MADISON, Wis. , Jan. 15, 2015  BellBrook ... for drug discovery, announced the launch of a ... of the company,s Transcreener UDP Assay, a high ... enzymes. The new assay will allow for sensitive ...
(Date:1/22/2015)... , Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... market, reports on the recent success of the Wocket™ smart wallet at ... Wocket smart wallet was named as one of the "11 Hot Products ... Best Products Launched At CES So Far" by Newseveryday.com and "The top ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... del Toro Research Station and Galeta Point Marine ... and a major coral bleaching event in the ... Atmospheric Administration, NOAA, issued an advisory in July ... Caribbean region, there had been no clear indication ...
... conference held in Brussels today, the International Osteoporosis Foundation (IOF), ... Group called on health care professionals and health policy officials ... call to action was made at the launch of a ... World Osteoporosis Day on October 20, 2010. Taking ...
... Gardeners could help maintain bumblebee populations by growing plants with ... to field observations of the common snapdragon, Antirrhinum majus ... Bees are important pollinators of crops as well as ... institute of the BBSRC, is committed to research that can ...
Cached Biology News:Smithsonian reports regional sea temperature rise and coral bleaching event in Western Caribbean 2IOF campaign puts spotlight on vastly under-diagnosed and under-treated spinal fractures 2Landing lights for bumblebees 2
Coating : Poly-D-Lysine ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vol working : 2.5-3.0 ml ...
...
BD BioCoat Collagen IV 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse collagen type IV....
... primers are designed for sequencing inserts cloned ... T7, or T3 RNA polymerase promoters, or ... supplied at a concentration of 0.1 µg/µl ... in DNA sequencing reactions using SequiTherm™ EXCEL™ ...
Biology Products: